Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 165

Results For "cell"

2107 News Found

ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’
Biotech | May 06, 2022

ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’

The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups


TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea
Biotech | May 05, 2022

TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea

The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness


Evonik opens its first Zero Liquid Discharge plant in India
Sustainability | May 05, 2022

Evonik opens its first Zero Liquid Discharge plant in India

Evonik in association with Remondis has opened its first plant in India to ensure Zero Liquid Discharge. It is located at Dombivli in Western Maharashtra


Gland launches Bortezomib in the US market
Drug Approval | May 04, 2022

Gland launches Bortezomib in the US market

Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma


Pfizer sets up global drug development centre in Chennai
News | May 04, 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia


Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical
Biotech | May 02, 2022

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical

Avacc 3 has significant advantages over existing whooping cough vaccines


USFDA concludes inspection of Shilpa Medicare with four observations
News | May 02, 2022

USFDA concludes inspection of Shilpa Medicare with four observations

The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory


Inmagene receives USFDA's IND clearance for ox40 antagonist
Biotech | May 01, 2022

Inmagene receives USFDA's IND clearance for ox40 antagonist

The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients


BeiGene to open new site at Princeton, New Jersey
Biotech | May 01, 2022

BeiGene to open new site at Princeton, New Jersey

Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines


India’s pharma exports grow by 103% since 2013-14
News | May 01, 2022

India’s pharma exports grow by 103% since 2013-14

Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions